Bodicoat Danielle H, Schoemaker Minouk J, Jones Michael E, McFadden Emily, Griffin James, Ashworth Alan, Swerdlow Anthony J
Breast Cancer Res. 2014 Feb 4;16(1):R18. doi: 10.1186/bcr3613.
Breast development and hormonal changes at puberty might affect breast cancer risk, but epidemiological analyses have focussed largely on age at menarche and not at other pubertal stages.
We investigated associations between the timing of pubertal stages and breast cancer risk using data from a cohort study of 104,931 women (Breakthrough Generations Study, UK, 2003-2013). Pubertal variables were reported retrospectively at baseline. Breast cancer risk was analysed using Cox regression models with breast cancer diagnosis as the outcome of interest, attained age as the underlying time variable, and adjustment for potentially confounding variables.
During follow-up (mean = 4.1 years), 1094 breast cancers (including ductal carcinoma in situ) occurred. An increased breast cancer risk was associated with earlier thelarche (age when breast growth begins; HR [95% CI] = 1.23 [1.02, 1.48], 1 [referent] and 0.80 [0.69, 0.93] for ≤10, 11-12 and ≥13 years respectively), menarche (initiation of menses; 1.06 [0.93, 1.21], 1 [referent] and 0.78 [0.62, 0.99] for ≤12, 13-14 and ≥15 years), regular periods (0.99 [0.83, 1.18], 1 [referent] and 0.74 [0.59, 0.92] for ≤12, 13-14 and ≥15 years) and age reached adult height (1.25 [1.03, 1.52], 1 [referent] and 1.07 [0.87, 1.32] for ≤14, 15-16 and ≥17 years), and with increased time between thelarche and menarche (0.87 [0.65, 1.15], 1 [referent], 1.14 [0.96, 1.34] and 1.27 [1.04, 1.55] for <0, 0, 1 and ≥2 years), and shorter time between menarche and regular periods (1 [referent], 0.87 [0.73, 1.04] and 0.66 [0.50, 0.88] for 0, 1 and ≥2 years). These associations were generally similar when considered separately for premenopausal and postmenopausal breast cancer.
Breast duct development may be a time of heightened susceptibility to risk of carcinogenesis, and greater attention needs to be given to the relation of breast cancer risk to the different stages of puberty.
青春期乳房发育和激素变化可能会影响乳腺癌风险,但流行病学分析主要集中在初潮年龄,而非其他青春期阶段。
我们利用一项对104931名女性的队列研究(英国突破世代研究,2003 - 2013年)的数据,调查青春期各阶段时间与乳腺癌风险之间的关联。青春期变量在基线时进行回顾性报告。以乳腺癌诊断为感兴趣的结局,达到的年龄为潜在时间变量,并对潜在混杂变量进行调整,使用Cox回归模型分析乳腺癌风险。
在随访期间(平均4.1年),发生了1094例乳腺癌(包括原位导管癌)。乳腺癌风险增加与乳房发育初现较早(乳房开始生长的年龄;≤10岁、11 - 12岁和≥13岁时的风险比[95%置信区间]分别为1.23[1.02, 1.48]、1[参照值]和0.80[0.69, 0.93])、初潮(月经初潮;≤12岁、13 - 14岁和≥15岁时分别为1.06[0.93, 1.21]、1[参照值]和0.78[0.62, 0.99])、规律月经(≤12岁、13 - 14岁和≥15岁时分别为0.99[0.83, 1.18]、1[参照值]和0.74[0.59, 0.92])以及达到成人身高的年龄(≤14岁、15 - 16岁和≥17岁时分别为1.25[1.03, 1.52]、1[参照值]和1.07[0.87, 1.32])相关,并且与乳房发育初现和初潮之间的时间间隔增加(<0年、0年、1年和≥2年时分别为0.87[0.65, 1.15]、1[参照值]、1.14[0.96, 1.34]和1.27[1.04, 1.55])以及初潮和规律月经之间的时间间隔缩短(0年、1年和≥2年时分别为1[参照值]、0.87[0.73, 1.04]和0.66[0.50, 0.88])相关。当分别考虑绝经前和绝经后乳腺癌时,这些关联通常相似。
乳腺导管发育可能是致癌风险易感性增加的时期,需要更加关注乳腺癌风险与青春期不同阶段的关系。